Madrigal Pharmaceuticals (NASDAQ:MDGL) rose 2% in after hours trading amid some takeover speculation.
There's speculation that Madrigal (MDGL) may have attracted interest from a large pharmaceutical company, according to a Betaville "uncooked" alert that circulated on Friday.
Madrigal (MDGL) has a market cap of $6.6 billion and short interest of 18.6%.
The latest speculation comes after a Bloomberg report in 2018 that the company received takeover interest from other drugmakers eyeing treatments for a liver disease linked to obesity.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.